-
Signature
-
/s/ Brian Grube, Attorney-in-Fact
-
Stock symbol
-
INTA
-
Transactions as of
-
Jun 12, 2023
-
Transactions value $
-
-$539,252
-
Form type
-
4
-
Date filed
-
6/14/2023, 05:29 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
INTA |
Common Stock |
Options Exercise |
$11.9K |
+2.97K |
+0.54% |
$3.99* |
558K |
Jun 12, 2023 |
Direct |
F1 |
transaction |
INTA |
Common Stock |
Sale |
-$146K |
-2.97K |
-0.53% |
$49.01 |
555K |
Jun 12, 2023 |
Direct |
F1, F2, F3 |
transaction |
INTA |
Common Stock |
Options Exercise |
$35.9K |
+9.01K |
+1.62% |
$3.99* |
564K |
Jun 13, 2023 |
Direct |
F1 |
transaction |
INTA |
Common Stock |
Sale |
-$441K |
-9.01K |
-1.6% |
$49.01 |
555K |
Jun 13, 2023 |
Direct |
F1, F3, F4 |
holding |
INTA |
Common Stock |
|
|
|
|
|
150K |
Jun 12, 2023 |
By Gambatte LLC |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
INTA |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-2.97K |
-0.61% |
$0.00 |
483K |
Jun 12, 2023 |
Common Stock |
2.97K |
$3.99 |
Direct |
F1, F6 |
transaction |
INTA |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-9.01K |
-1.87% |
$0.00 |
474K |
Jun 13, 2023 |
Common Stock |
9.01K |
$3.99 |
Direct |
F1, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: